Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decidual Stromal Cells for Toxicity and Inflammation in Allo-HSCT
NCT02175303Phase 2Unknown
- Sponsor
- Karolinska Institutet
- Start
- Dec 2013
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
A Phase 2 trial of decidua stroma cells in acute lung injury (ALI), graft-versus-host disease (GVHD), hemorrhage, inflammation, sponsored by Karolinska Institutet. Status: unknown.
02
Drugs
decidua stroma cells
03
Conditions
acute lung injury (ALI)graft-versus-host disease (GVHD)hemorrhageinflammation
Beyond the preview
Go deeper on NCT02175303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02175303.